MedTrace Logo

The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation

NCT02162433 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2020-04-09

Study results available
· View outcomes & findings →

Summary

The investigators aim to investigate the effect of dexmedetomidine on the perioperative respiratory complications in this patient population undergoing both awake and deep tracheal extubation.

Conditions

Interventions

DRUG

Normal Saline

to arms 2,4. Serves as the placebo.

DRUG

Dexmedetomidine

to arms 1,3

Sponsors & Collaborators

  • Massachusetts Eye and Ear Infirmary

    lead OTHER

Principal Investigators

  • Makara Cayer, MD · MEEI/ Harvard Medical School

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2018-04-30
Completion
2018-04-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162433 on ClinicalTrials.gov